Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 3Thoracic 1Sarcoma 1Genitourinary 1CNS 1

Conditions

Colorectal Neoplasms 135Neoplasms 37Pancreatic Neoplasms 34Stomach Neoplasms 27Colonic Neoplasms 23Neoplasm Metastasis 20Rectal Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Esophageal Neoplasms 10Cholangiocarcinoma 10Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Biliary Tract Neoplasms 8Adenocarcinoma Of Esophagus 8Ovarian Neoplasms 7Triple Negative Breast Neoplasms 6Gallbladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Gastrointestinal Neoplasms 5Digestive System Neoplasms 5Breast Neoplasms 5Advanced Solid Tumors 5Squamous Cell Carcinoma of Head and Neck 4Solid Tumors 4Melanoma 4Intestinal Neoplasms 4Carcinoma, Pancreatic Ductal 4Carcinoma, Hepatocellular 4Advanced Solid Tumor 4Small Cell Lung Carcinoma 3

Interventions

pembrolizumab 44Paclitaxel 37Carboplatin 30Doxorubicin 11Cisplatin 11Bevacizumab 11lenvatinib 9Nivolumab 9Docetaxel 9Fulvestrant 8Gemcitabine 7Oxaliplatin 6Fluorouracil 6Pemetrexed 5Letrozole 5Ipilimumab 5Cetuximab 5spartalizumab 4selinexor 4dostarlimab 4Trastuzumab 4Irinotecan 4trastuzumab deruxtecan 3tisotumab vedotin 3serabelisib 3sacituzumab govitecan 3ribociclib 3olaparib 3epacadostat 3durvalumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Endometrial Neoplasms × Leucovorin × Clear all
NCT05919264 2026-05-28

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT06607185 2026-05-26

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Eli Lilly and Company

Phase 1 Active not recruiting
750 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT03314935 2025-08-12

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Incyte Corporation

Phase 1/2 Completed
149 enrolled 35 charts
GastrointestinalGynecologic

Biliary Tract Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡